Literature DB >> 25360546

Structure and dynamics of apical membrane antigen 1 from Plasmodium falciparum FVO.

San Sui Lim1, Wei Yang, Bankala Krishnarjuna, Komagal Kannan Sivaraman, Indu R Chandrashekaran, Itamar Kass, Christopher A MacRaild, Shane M Devine, Cael O Debono, Robin F Anders, Martin J Scanlon, Peter J Scammells, Raymond S Norton, Sheena McGowan.   

Abstract

Apical membrane antigen 1 (AMA1) interacts with RON2 to form a protein complex that plays a key role in the invasion of host cells by malaria parasites. Blocking this protein-protein interaction represents a potential route to controlling malaria and related parasitic diseases, but the polymorphic nature of AMA1 has proven to be a major challenge to vaccine-induced antibodies and peptide inhibitors exerting strain-transcending inhibitory effects. Here we present the X-ray crystal structure of AMA1 domains I and II from Plasmodium falciparum strain FVO. We compare our new structure to those of AMA1 from P. falciparum 3D7 and Plasmodium vivax. A combination of normalized B factor analysis and computational methods has been used to investigate the flexibility of the domain I loops and how this correlates with their roles in determining the strain specificity of human antibody responses and inhibitory peptides. We also investigated the domain II loop, a key region involved in inhibitor binding, by comparison of multiple AMA1 crystal structures. Collectively, these results provide valuable insights that should contribute to the design of strain-transcending agents targeting P. falciparum AMA1.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25360546     DOI: 10.1021/bi5012089

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Computational and biophysical approaches to protein-protein interaction inhibition of Plasmodium falciparum AMA1/RON2 complex.

Authors:  Emilie Pihan; Roberto F Delgadillo; Michelle L Tonkin; Martine Pugnière; Maryse Lebrun; Martin J Boulanger; Dominique Douguet
Journal:  J Comput Aided Mol Des       Date:  2015-03-31       Impact factor: 3.686

Review 2.  Antimalarial drug discovery targeting apical membrane antigen 1.

Authors:  Shane M Devine; Christopher A MacRaild; Raymond S Norton; Peter J Scammells
Journal:  Medchemcomm       Date:  2016-11-04       Impact factor: 3.597

3.  The Anopheles-midgut APN1 structure reveals a new malaria transmission-blocking vaccine epitope.

Authors:  Sarah C Atkinson; Jennifer S Armistead; Derrick K Mathias; Maurice M Sandeu; Dingyin Tao; Nahid Borhani-Dizaji; Brian B Tarimo; Isabelle Morlais; Rhoel R Dinglasan; Natalie A Borg
Journal:  Nat Struct Mol Biol       Date:  2015-06-15       Impact factor: 15.369

4.  Immunization with the Malaria Diversity-Covering Blood-Stage Vaccine Candidate Plasmodium falciparum Apical Membrane Antigen 1 DiCo in Complex with Its Natural Ligand PfRon2 Does Not Improve the In Vitro Efficacy.

Authors:  Holger Spiegel; Alexander Boes; Rolf Fendel; Andreas Reimann; Stefan Schillberg; Rainer Fischer
Journal:  Front Immunol       Date:  2017-06-27       Impact factor: 7.561

Review 5.  Applications of (19)F-NMR in Fragment-Based Drug Discovery.

Authors:  Raymond S Norton; Eleanor W W Leung; Indu R Chandrashekaran; Christopher A MacRaild
Journal:  Molecules       Date:  2016-07-16       Impact factor: 4.411

6.  Reverse immunodynamics: a new method for identifying targets of protective immunity.

Authors:  Katrina J Spensley; Paul S Wikramaratna; Bridget S Penman; Andrew Walker; Adrian L Smith; Oliver G Pybus; Létitia Jean; Sunetra Gupta; José Lourenço
Journal:  Sci Rep       Date:  2019-02-15       Impact factor: 4.379

7.  Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination.

Authors:  Jason A Bailey; Andrea A Berry; Mark A Travassos; Amed Ouattara; Sarah Boudova; Emmanuel Y Dotsey; Andrew Pike; Christopher G Jacob; Matthew Adams; John C Tan; Ryan M Bannen; Jigar J Patel; Jozelyn Pablo; Rie Nakajima; Algis Jasinskas; Sheetij Dutta; Shannon Takala-Harrison; Kirsten E Lyke; Matthew B Laurens; Amadou Niangaly; Drissa Coulibaly; Bourema Kouriba; Ogobara K Doumbo; Mahamadou A Thera; Philip L Felgner; Christopher V Plowe
Journal:  Sci Rep       Date:  2020-03-03       Impact factor: 4.379

8.  Structural and immunological characterization of an epitope within the PAN motif of ectodomain I in Babesia bovis apical membrane antigen 1 for vaccine development.

Authors:  Amarin Rittipornlertrak; Boondarika Nambooppha; Anucha Muenthaisong; Veerasak Punyapornwithaya; Saruda Tiwananthagorn; Yang-Tsung Chung; Bumduuren Tuvshintulga; Thillaiampalam Sivakumar; Naoaki Yokoyama; Nattawooti Sthitmatee
Journal:  PeerJ       Date:  2021-07-16       Impact factor: 2.984

9.  An Extended Surface Loop on Toxoplasma gondii Apical Membrane Antigen 1 (AMA1) Governs Ligand Binding Selectivity.

Authors:  Michelle L Parker; Martin J Boulanger
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

10.  Stability of the Plasmodium falciparum AMA1-RON2 Complex Is Governed by the Domain II (DII) Loop.

Authors:  Roberto F Delgadillo; Michelle L Parker; Maryse Lebrun; Martin J Boulanger; Dominique Douguet
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.